Cardiac myocardial bridges, or myocardial bridges, generally have no effect on life expectancy. Only myocardial bridges that severely affect heart function leading to heart failure will result in shorter survival. A myocardial bridge is a condition in which a segment of a coronary artery travels into the myocardium, and when the heart contracts, the blood vessel traveling into the myocardium is compressed, resulting in insufficient blood supply to the myocardium during systole. In general, myocardial bridges have a more insidious onset, and a large proportion of asymptomatic patients, this group of people generally do not need special treatment, myocardial bridges on the life expectancy of the impact is also negligible, can be ignored. Patients with symptomatic myocardial bridges can be treated medically or surgically to control the progression of the disease and relieve discomfort. Medication is often provided by beta-blockers such as metoprolol. Surgery is commonly used to release myocardial bridges. It is necessary to choose the appropriate treatment plan under the guidance of professional doctors. Generally, the life expectancy of treated patients will not be significantly shortened. Only severe myocardial bridge patients with heart failure will have a shorter life expectancy, and the specific length of time varies according to the patient’s own situation.